Warning! GuruFocus detected
4 Severe warning signs
with 4Y4.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
BIO-UV Group
ISIN : FR0013345493
Compare
Compare
Traded in other countries / regions
ALTUV.France4Y4.GermanyBOUVF.USA IPO Date
2021-02-15Description
BIO-UV Group is a manufacturer of ultraviolet (UV) water treatment equipment in France. It designs, manufactures and markets systems and concepts of disinfection by ultraviolet light (UV-C) adapted to the number of applications. The company offers products for disinfecting swimming pools and private and collective hot tubs, treating wastewater, producing drinking water, treating bilge water from ships and water from aquariums.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.78 | |||||
| Debt-to-EBITDA | 5.32 | |||||
| Interest Coverage | 2 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.17 | |||||
| Beneish M-Score | -2.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.6 | |||||
| 3-Year EBITDA Growth Rate | 11 | |||||
| 3-Year EPS without NRI Growth Rate | -4.2 | |||||
| 3-Year Book Growth Rate | 1.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 34.97 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.21 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.14 | |||||
| 9-Day RSI | 32.03 | |||||
| 14-Day RSI | 34.58 | |||||
| 3-1 Month Momentum % | -13.45 | |||||
| 6-1 Month Momentum % | -2.2 | |||||
| 12-1 Month Momentum % | -18.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.69 | |||||
| Quick Ratio | 0.83 | |||||
| Cash Ratio | 0.22 | |||||
| Days Inventory | 334.05 | |||||
| Days Sales Outstanding | 45.79 | |||||
| Days Payable | 123.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.6 | |||||
| 3-Year Average Share Buyback Ratio | -1.1 | |||||
| Shareholder Yield % | 14.82 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60 | |||||
| Operating Margin % | 4.99 | |||||
| Net Margin % | -1.76 | |||||
| FCF Margin % | 13.35 | |||||
| ROE % | -2.22 | |||||
| ROA % | -1.02 | |||||
| ROIC % | -9.82 | |||||
| 3-Year ROIIC % | 4.11 | |||||
| ROC (Joel Greenblatt) % | 5.01 | |||||
| ROCE % | 1.72 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 8.74 | |||||
| PE Ratio without NRI | 16.98 | |||||
| Price-to-Owner-Earnings | 4.25 | |||||
| PEG Ratio | 0.43 | |||||
| PS Ratio | 0.42 | |||||
| PB Ratio | 0.53 | |||||
| Price-to-Free-Cash-Flow | 3.13 | |||||
| Price-to-Operating-Cash-Flow | 2.48 | |||||
| EV-to-EBIT | 48.54 | |||||
| EV-to-EBITDA | 9.48 | |||||
| EV-to-Revenue | 1.11 | |||||
| EV-to-FCF | 8.32 | |||||
| Price-to-GF-Value | 0.3 | |||||
| Price-to-Projected-FCF | 1.3 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.66 | |||||
| Earnings Yield (Greenblatt) % | 2.06 | |||||
| FCF Yield % | 23.39 | |||||
| Forward Rate of Return (Yacktman) % | 13.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BIO-UV Group Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 41.095 | ||
| EPS (TTM) (€) | -0.059 | ||
| Beta | -0.04 | ||
| 3-Year Sharpe Ratio | -0.55 | ||
| 3-Year Sortino Ratio | -0.77 | ||
| Volatility % | 35.29 | ||
| 14-Day RSI | 34.58 | ||
| 14-Day ATR (€) | 0.032376 | ||
| 20-Day SMA (€) | 1.855 | ||
| 12-1 Month Momentum % | -18.16 | ||
| 52-Week Range (€) | 1.482 - 2.39 | ||
| Shares Outstanding (Mil) | 13.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BIO-UV Group Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BIO-UV Group Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
BIO-UV Group Frequently Asked Questions
What is BIO-UV Group(FRA:4Y4)'s stock price today?
The current price of FRA:4Y4 is €1.75. The 52 week high of FRA:4Y4 is €2.39 and 52 week low is €1.48.
When is next earnings date of BIO-UV Group(FRA:4Y4)?
The next earnings date of BIO-UV Group(FRA:4Y4) is .
Does BIO-UV Group(FRA:4Y4) pay dividends? If so, how much?
BIO-UV Group(FRA:4Y4) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers